ganirelix

Poland

Drugs containing this active substance

  • FYREMADEL

    The medicine is used in women participating in assisted reproduction programs (e.g., in vitro fertilization) to prevent premature ovulation by inhibiting the rise in luteinizing hormone (LH) levels.

    Form: solution for injection in ampoule-syringe

    Active substance Dosage
    ganirelix 0,25 mg/0,5 ml

    ATC: H01CC01

    Manufacturer: Sun Pharmaceutical Industries Europe B.V.

  • The medicinal product is used in women participating in assisted reproduction programs (e.g., in vitro fertilization) to prevent premature release of eggs (ovulation).

    Form: solution for injection in ampoule-syringe

    Active substance Dosage
    ganirelix 0,25 mg/0,5 ml

    ATC: H01CC01

    Manufacturer: GP-PHARM S.A.